Research indicates that mutations in COPA are associated with autoimmune diseases and that COPA mutants induce the production and signaling of Type I IFN in a dominant-negative manner through STING, thereby controlling the autoimmune inflammation process [27]. The gene discussed is COPA; the disease is autoimmune disease.